Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.

The drugmaker hopes an Nvidia-chip powered supercomputer will help it find new drugs and accelerate lengthy R&D timelines.

The US military is upgrading a Cold War base in the Caribbean it abandoned 20 years ago. Experts say it’s a step towards ...

Today Leo takes a look at the new Asus rog Zephyrus G14 with Ryzen 9 4900HS. It is extremely impressive - and today he shows ...

Update on WTX-124 Phase 1/1b clinical trial interim data and End of Phase 1 meeting with the U.S. Food & Drug Administration (FDA) is ...

A 2021 White House analysis projected that overdose deaths could surge to 165,000 a year by 2025 if the U.S. didn’t act.

The far‑right isn’t just using AI for propaganda — they’re embracing the worst‑looking AI art of all. Find out why it fits ...

Zydus Lifesciences: The company’s board will meet on November 6 to consider raising funds of up to Rs. 5,000 cr through ...

Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to ...

Progressive Maryland celebrates 25 years, looks to the work ahead, the LGBTQIA+ reaches out with a survey ahead of the 2026 ...

Biotech stock Alvotech SA (NASDAQ:ALVO) is plummeting to three-year lows, down 29.9% at $5.36 at last check. The FDA declined to approve the company's arthritis drug, sending a list of deficiencies ...

What’s holding companies back from taking full advantage of the technology, and which trends should they keep in mind?